Molecular Tumor Board: Series 10 || Interesting Cases || Don't Miss || Every Month 2nd&4th Saturday скачать в хорошем качестве

Molecular Tumor Board: Series 10 || Interesting Cases || Don't Miss || Every Month 2nd&4th Saturday

▶️Watch Now 📌Subscribe Now 🧬 ALK fusion + TP53 loss — Oncogenic driver active, tumor suppressor silenced. 🧬 KRAS + APC + TP53 — Colorectal mutational signature in pancreatic tissue. 🩸 HER2 3+ / ER+ / PIK3CA mut — Dual pathway activation; trastuzumab resistance likely via PI3K escape. 💠 ERBB2 Y310C (VAF 1.8%) — Subclonal variant; not founding clone, low therapeutic priority. 🔬 BARD1 VUS — HR pathway gene alteration; functional impact undetermined, germline correlation pending. 💊 KRAS G12A — Prevalent allele, limited targeted options (sotorasib/adagrasib G12C-specific). 🧬 PIK3CA missense — PI3K/AKT axis dysregulated; endocrine therapy resistance mechanism in HR+ disease Case 1 – 00:25 Case 2 – 41:03 Case 3 – 50:47 Case 4 – 1:40:29 Case 5 – 1:00:56 Case 6 – 1:16:15 Case 7 – 1:27:01 Case 8 – 34:58 📲 Join WhatsApp Group https://chat.whatsapp.com/Cb3lAc6VrZD... ▶️Presented & Edited By Prof. Arun Seshachalam Medical Oncologist ▶️More Information 📩Email: [email protected] 📞Contact: 88258 05263 🌐Website: https://www.realworldevidence.in/